Fizazi K - Search Results

1

Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases.

Saad F, Brown JE, Van Poznak C, Ibrahim T, Stemmer SM, Stopeck AT, Diel IJ, Takahashi S, Shore N, Henry DH, Barrios CH, Facon T, Senecal F, Fizazi K, Zhou L, Daniels A, Carrière P, Dansey R. Saad F, et al. Among authors: fizazi k. Ann Oncol. 2012 May;23(5):1341-1347. doi: 10.1093/annonc/mdr435. Epub 2011 Oct 10. Ann Oncol. 2012. PMID: 21986094 Free article.

2

Squamous cell carcinoma of the penis: multivariate analysis of prognostic factors and natural history in monocentric study with a conservative policy.

Soria JC, Fizazi K, Piron D, Kramar A, Gerbaulet A, Haie-Meder C, Perrin JL, Court B, Wibault P, Théodore C. Soria JC, et al. Among authors: fizazi k. Ann Oncol. 1997 Nov;8(11):1089-98. doi: 10.1023/a:1008248319036. Ann Oncol. 1997. PMID: 9426328 Free article.

3

Is òne cycle every three or four weeks' obsolete? A critical review of dose-dense chemotherapy in solid neoplasms.

Fizazi K, Zelek L. Fizazi K, et al. Ann Oncol. 2000 Feb;11(2):133-49. doi: 10.1023/a:1008344014518. Ann Oncol. 2000. PMID: 10761747 Free article. Review.

4

Carcinoma of an unknown primary site: a chemotherapy strategy based on histological differentiation--results of a prospective study.

Saghatchian M, Fizazi K, Borel C, Ducreux M, Ruffié P, Le Chevalier T, Théodore C. Saghatchian M, et al. Among authors: fizazi k. Ann Oncol. 2001 Apr;12(4):535-40. doi: 10.1023/a:1011129429499. Ann Oncol. 2001. PMID: 11398889 Free article. Clinical Trial.

5

Gastric metastases from breast cancer: a retrospective series of 12 patients.

Zelek L, Cottu PH, Mignot L, de Roquancourt A, Fizazi K, Cojean-Zelek I, Espie M, Marty M. Zelek L, et al. Among authors: fizazi k. Am J Clin Oncol. 2001 Aug;24(4):363-5. doi: 10.1097/00000421-200108000-00009. Am J Clin Oncol. 2001. PMID: 11474262

6

Combination of raltitrexed and oxaliplatin is an active regimen in malignant mesothelioma: results of a phase II study.

Fizazi K, Doubre H, Le Chevalier T, Riviere A, Viala J, Daniel C, Robert L, Barthélemy P, Fandi A, Ruffié P. Fizazi K, et al. J Clin Oncol. 2003 Jan 15;21(2):349-54. doi: 10.1200/JCO.2003.05.123. J Clin Oncol. 2003. PMID: 12525529 Clinical Trial.

7

A phase II monocentric study of oxaliplatin in combination with gemcitabine (GEMOX) in patients with advanced/metastatic transitional cell carcinoma (TCC) of the urothelial tract.

Theodore C, Bidault F, Bouvet-Forteau N, Abdelatif M, Fizazi K, di Palma M, Wibault P, de Crevoisier R, Laplanche A. Theodore C, et al. Among authors: fizazi k. Ann Oncol. 2006 Jun;17(6):990-4. doi: 10.1093/annonc/mdl057. Epub 2006 Apr 6. Ann Oncol. 2006. PMID: 16600984 Free article. Clinical Trial.

8

Treatment of patients with specific subsets of carcinoma of an unknown primary site.

Fizazi K. Fizazi K. Ann Oncol. 2006 Sep;17 Suppl 10:x177-80. doi: 10.1093/annonc/mdl256. Ann Oncol. 2006. PMID: 17018719 Free article. Review. No abstract available.

9

High detection rate of circulating tumor cells in blood of patients with prostate cancer using telomerase activity.

Fizazi K, Morat L, Chauveinc L, Prapotnich D, De Crevoisier R, Escudier B, Cathelineau X, Rozet F, Vallancien G, Sabatier L, Soria JC. Fizazi K, et al. Ann Oncol. 2007 Mar;18(3):518-21. doi: 10.1093/annonc/mdl419. Ann Oncol. 2007. PMID: 17322541 Free article.

10

The role of Src in prostate cancer.

Fizazi K. Fizazi K. Ann Oncol. 2007 Nov;18(11):1765-73. doi: 10.1093/annonc/mdm086. Epub 2007 Apr 10. Ann Oncol. 2007. PMID: 17426060 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

517 results

Search Page